investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

The role of PRDM1 in epigenetic regulation and tumor suppression

Scott Moore Carlson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Scott Moore Carlson

Stanford University

Stanford, United States

Related projects

Jon C Aster

Oncogenic Notch Signaling

Leukaemia

Pathology Hematology and hematologic malignancies

Charalampos Kalodimos

Mechanisms of autoinhibition and activation of the Abl kinase

Leukaemia

Robert K Bradley

Genetic and molecular basis for SRSF2 mutations in myelodysplasia

Leukaemia

Suresh Ambudkar

Biochemical Analysis of Multidrug Resistance-linked Transport Proteins

Leukaemia

Hematology and hematologic malignancies Pathology

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Pathology Hematology and hematologic malignancies

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Mary Ellen Conley

Genetic Etiology of Agammaglobulinemia with Absent B Cells

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

Leukaemia

Bruce R Blazar

Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)

Leukaemia

Hematology and hematologic malignancies Pathology